Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

N D Tronko, V M Pushkarev

    Tsitologiia I Genetika
    |November 29, 2018
    PubMed
    Summary
    This summary is machine-generated.

    This review explores the genetic basis of papillary thyroid carcinoma, highlighting the role of ionizing radiation and inflammation in its development. It emphasizes the involvement of the nuclear transcription factor NF-κB in cancer initiation and progression.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Plasma Apolipoproteins A1/B and OxLDL Levels in Patients with Covid-19 As Possible Markers of the Disease.

    Cytology and genetics·2021
    Same author

    [DNA fragmentation rate in human thyroid tissue and carcinomas and its change under the influence of a-tocopherol and iodine ions in vitro].

    Problemy endokrinologii·2019
    Same author

    Differentiated thyroid carcinomas associated with chronic thyroiditis: biological and clinical properties.

    Experimental oncology·2018
    Same author

    Protein kinase Akt activity in human thyroid tumors.

    Ukrainian biochemical journal·2017
    Same author

    BIOCHEMICAL EFFECTS OF ESTROGENS IN NON-REPRODUCTIVE ORGANS.

    Ukrainian biochemical journal·2016
    Same author

    INHIBITOR OF THE TRANSCRIPTION FACTOR NF-κB, DHMEQ, ENHANCES THE EFFECT OF PACLITAXEL ON CELLS OF ANAPLASTIC THYROID CARCINOMA IN VITRO AND IN VIVO.

    Ukrainian biochemical journal·2015
    Same journal

    TSitologiia i genetika·2018
    Same journal

    TSitologiia i genetika·2018
    Same journal

    TSitologiia i genetika·2018
    Same journal

    TSitologiia i genetika·2018
    Same journal

    TSitologiia i genetika·2018
    Same journal

    TSitologiia i genetika·2018
    See all related articles

    Area of Science:

    • Oncology
    • Molecular Biology
    • Genetics

    Background:

    • Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer.
    • Understanding its molecular pathogenesis is crucial for effective treatment strategies.
    • Environmental factors, such as ionizing radiation, are implicated in thyroid cancer development.

    Purpose of the Study:

    • To review the fundamental molecular genetic mechanisms underlying papillary thyroid carcinoma formation.
    • To analyze the contribution of ionizing radiation to thyroid cancer pathogenesis.
    • To elucidate the role of the tumor microenvironment, inflammation, and NF-κB in PTC initiation and progression.

    Main Methods:

    • Literature review of existing data on papillary thyroid carcinoma.
    • Analysis of molecular genetic studies.

    Related Experiment Videos

  • Examination of research on ionizing radiation and cancer.
  • Investigation of the tumor microenvironment and inflammatory pathways.

    • Main Results:

    • Key molecular genetic alterations driving papillary thyroid carcinoma have been identified.
    • Ionizing radiation exposure is a significant risk factor contributing to thyroid cancer.
    • The tumor microenvironment, characterized by inflammation and the activity of nuclear transcription factor NF-κB, plays a critical role in initiating and promoting papillary thyroid carcinoma.

    Conclusions:

    • Molecular genetic factors are central to papillary thyroid carcinoma development.
    • Ionizing radiation and inflammatory processes, particularly involving NF-κB, are key contributors to thyroid cancer.
    • Further research into these mechanisms can inform targeted therapies for papillary thyroid carcinoma.